Paragon Bioservices, Inc.
Lisa Rogosa Jones is an experienced scientist with a robust background in research and associate roles within prominent biotechnology and pharmaceutical companies. Since September 2015, Lisa has been serving as an Associate Scientist II at Paragon Bioservices, Inc. Previously, Lisa worked as a Research Associate in Dr. Daniel Kelly's Lab at Sanford Burnham Prebys Medical Discovery Institute from March 2013 to August 2015, and held Research Associate positions at Pronutria and Vertex Pharmaceuticals from July 2012 to January 2013 and May 2010 to December 2012, respectively. Lisa's early career included roles as a Production Scientist II at Beckman Coulter Genomics and a Research Scholar at Lehigh Valley Health Network. Lisa also gained teaching experience as a Teaching Assistant while attending Lafayette College, where Lisa earned a Bachelor of Science in Biology in 2008.
Paragon Bioservices, Inc.
With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. and Europe. An experienced partner, Catalent Cell & Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs.